Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

Synchronous Bilateral Breast Carcinoma in a Patient with Cowden Syndrome with PTEN Mutation: A Case Report

Kwon SY, Yeo SH, Ha JS, Kang SH

  • J Breast Dis.
  • 2018 Dec;6(2):79-83.
  • doi: 10.14449/jbd.2018.6.2.79
Cowden syndrome (CS), also known as multiple hamartomas syndrome, is a rare hereditary autosomal dominant disorder caused by a germline mutation in the phosphatase and tensin homolog (PTEN) gene mapped...
Primary Angiosarcoma of the Breast: A Case Report

Kim RM, Lee H, Park H

  • J Breast Dis.
  • 2018 Dec;6(2):73-78.
  • doi: 10.14449/jbd.2018.6.2.73
Primary angiosarcoma of the breast is extremely rare and is observed in 0.0005% to 0.05% of primary breast tumor cases. The diagnosis of this tumor is difficult due to its...
Clinical Implications According to Diagnostic Methods of Human Epidermal Growth Factor Receptor 2 Positivity in Breast Cancer: A Retrospective Study

Kim BK, Jeong J, Han W, Yoon TI, Seong MK, Jung JH, Jung SH, Lee J, Sun WY, Korean Breast Cancer Society

  • J Breast Dis.
  • 2018 Dec;6(2):60-72.
  • doi: 10.14449/jbd.2018.6.2.60
PURPOSE: According to American Society of Clinical Oncology/College of American Pathologists guidelines, breast cancer is human epidermal growth factor receptor 2 (HER2) positive if there is HER2 protein overexpression at...
Predicting Successful Conservative Surgery after Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer

Ko CS, Kim KM, Lee JW, Lee HS, Lee SB, Sohn G, Kim J, Kim HJ, Chung IY, Ko BS, Son BH, Ahn SD, Kim SB, Kim HH, Ahn SH

  • J Breast Dis.
  • 2018 Dec;6(2):52-59.
  • doi: 10.14449/jbd.2018.6.2.52
PURPOSE: This study aimed to determine whether clinicopathological factors are potentially associated with successful breast-conserving surgery (BCS) after neoadjuvant chemotherapy (NAC) and develop a nomogram for predicting successful BCS candidates,...
Efficacy of Combined Aromatase Inhibitor and Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Metastatic Breast Cancer

Kim SH, Choi J, Park CS, Kim HA, Noh WC, Seong MK

  • J Breast Dis.
  • 2018 Dec;6(2):46-51.
  • doi: 10.14449/jbd.2018.6.2.46
PURPOSE: Endocrine therapy is the preferred treatment for hormone receptor (HR)-positive metastatic breast cancer (MBC). We investigated the efficacy of combined aromatase inhibitor (AI) and luteinizing hormone-releasing hormone (LHRH) agonist...
Apoptosis and Cell Cycle Arrest in Two Human Breast Cancer Cell Lines by Dieckol Isolated from Ecklonia cava

You SH, Kim JS, Kim YS

  • J Breast Dis.
  • 2018 Dec;6(2):39-45.
  • doi: 10.14449/jbd.2018.6.2.45
PURPOSE: Dieckol, a phlorotannin compound isolated from Ecklonia cava, has been reported to have antioxidant, antiviral, anti-inflammatory, and anticancer properties. The purpose of this study was to investigate its anticancer...
Development of an Excel Program for the Updated Eighth American Joint Committee on Cancer Breast Cancer Staging System

Jo J, Kim ET, Min JW, Chang MC

  • J Breast Dis.
  • 2018 Dec;6(2):35-38.
  • doi: 10.14449/jbd.2018.6.2.35
PURPOSE: The eighth American Joint Committee on Cancer staging system for breast cancer was recently published to more accurately predict the prognosis by adding biomarkers such as estrogen receptors, progesterone...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr